GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (FRA:8VP1) » Definitions » Market Cap

Avricore Health (FRA:8VP1) Market Cap : €12.54 Mil (As of Sep. 22, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Avricore Health Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Avricore Health's share price for the quarter that ended in Jun. 2024 was €0.107. Avricore Health's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 99.89 Mil. Therefore, Avricore Health's market cap for the quarter that ended in Jun. 2024 was €10.69 Mil.

Avricore Health's quarterly market cap declined from Dec. 2023 (€11.06 Mil) to Mar. 2024 (€7.94 Mil) but then increased from Mar. 2024 (€7.94 Mil) to Jun. 2024 (€10.69 Mil).

Avricore Health's annual market cap increased from Dec. 2021 (€9.27 Mil) to Dec. 2022 (€21.30 Mil) but then declined from Dec. 2022 (€21.30 Mil) to Dec. 2023 (€11.06 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Avricore Health's Enterprise Value for Today is €12.38 Mil.


Avricore Health Market Cap Historical Data

The historical data trend for Avricore Health's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health Market Cap Chart

Avricore Health Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.42 3.35 9.27 21.30 11.06

Avricore Health Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.65 12.16 11.06 7.94 10.69

Competitive Comparison of Avricore Health's Market Cap

For the Diagnostics & Research subindustry, Avricore Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avricore Health's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's Market Cap distribution charts can be found below:

* The bar in red indicates where Avricore Health's Market Cap falls into.



Avricore Health Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Avricore Health's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€0.111*99.6447
=€11.06

Avricore Health's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=€0.107*99.8897
=€10.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avricore Health  (FRA:8VP1) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Avricore Health Market Cap Related Terms

Thank you for viewing the detailed overview of Avricore Health's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Avricore Health Business Description

Traded in Other Exchanges
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and sale of testing panels.

Avricore Health Headlines

No Headlines